United States-based Conformal Medical Inc has named George Fazio as its new director, it was reported on Thursday.
Presently, Fazio is the president and chief executive officer of Corvia Medical. He has over three decades of executive experience in the cardiovascular space. He has served in various senior leadership positions with St Jude Medical, including serving as president of the United States and EMEA regions, and both the cardiovascular and cardiac surgery businesses. He also held the position of president of Health Care Services.
Andy Levine, co-founder and chief executive officer of Conformal Medical, said, 'We are very pleased to have George join Conformal's board of directors at this important time as we embark on our US IDE trial. We are confident that his strategic business insights, extensive knowledge in the cardiovascular market, and experience as an executive of a private medical device company will add tremendous value as we advance our technology through upcoming clinical and regulatory milestones.'
Lilly to acquire Merida Biosciences in USD2.875bn deal
GE HealthCare expands Vivid cardiovascular ultrasound portfolio with three new systems
Daiichi Sankyo data highlight real-world impact of bempedoic acid on cardiovascular risk
Revier Therapeutics closes EUR6m seed financing and launches operations
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
European Commission grants orphan designation for Lundbeck's asedebart
Hanmi Pharm enters exclusive licensing deal with Genentech for obesity therapy HM17321
PTC to acquire BLA-stage ST-920 Fabry disease programme
Olio Labs reveals study demonstrating AI-driven in vivo platform can predict clinical trial outcomes
Mezzion Pharma Co reports positive results from new in vivo study of udenafil